← Browse by Condition
Medical Condition

xerostomia

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for xerostomia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — xerostomia Clinical Trials

How many clinical trials are currently recruiting for xerostomia?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for xerostomia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for xerostomia?
xerostomia research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a xerostomia clinical trial?
Eligibility criteria for xerostomia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
University of Wisconsin, Madison 1 trial
Universidad de Granada 1 trial
The University of Hong Kong 1 trial

Recruiting Clinical Trials

NCT06392711 Phase 1
Recruiting
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Enrollment
36 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT05106608
Recruiting
Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
Enrollment
60 pts
Location
Spain
Sponsor
Universidad de Granada
View Trial →
NCT06465628
Recruiting
Acupressure on Xerostomia in Head and Neck Cancer Patients
Enrollment
126 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →

Related Conditions

head and neck cancer (2) graft versus host disease (1) sjogren s disease (1) head and neck neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology